Stoke Therapeutics Shares Are Trading Lower After the Company Announced the Pricing of an Upsized $125 Million Public Offering of 5,555,557 Common Shares at $13.50 per Share
Stoke Therapeutics宣布将5,555,557股普通股的1.25亿美元公开发行定价为每股13.50美元,此后,Stoke Therapeutics的股价走低